» Articles » PMID: 28538367

Identifying MiRNA-mRNA Regulation Network of Chronic Pancreatitis Based on the Significant Functional Expression

Overview
Specialty General Medicine
Date 2017 May 25
PMID 28538367
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this study was to explore the underlying molecular mechanism and potential molecular biomarkers of chronic pancreatitis (CP) and construct a miRNA-mRNA regulation network.

Methods: To explore the involvement of miRNAs in CP, we downloaded the miRNA and mRNA expression profiles of CP patients and healthy controls and identified the differentially expressed miRNAs and genes. Functional analysis was conducted and significant pathways were utilized. Finally, the miRNA-mRNA regulation network of CP was constructed.

Results: A total of 44 miRNA risk gene pathway relationships were identified, and a complex regulation network was constructed with 3 genes (ABL1, MYC, and ANAPC13) having the highest degree in affecting the network of CP. Importantly, 4 risk genes (NOTCH3, COX5A, THBS1, and KARS) and 1 risk miRNA (hsa-miR-324-5p) were identified with high prediction accuracy.

Conclusions: In conclusion, we analyzed miRNAs and mRNAs expression profiles in CP, 1 risk miRNA, and 4 risk genes were identified with high prediction accuracy as biomarkers of CP. Although further evaluation in clinical study is needed, our findings provide new insights into the pathogenesis of CP and may improve the diagnosis and therapy by identifying novel targets.

Citing Articles

microRNA-637/661 ameliorate hypoxic-induced pulmonary arterial hypertension by targeting TRIM29 signaling pathway.

Jiang L, Tao W, Liu J, Yang A, Zhou J Sci Rep. 2024; 14(1):27971.

PMID: 39543168 PMC: 11564567. DOI: 10.1038/s41598-024-79769-2.


Candidate circulating microRNA biomarkers in dogs with chronic pancreatitis.

Armstrong S, Hunter R, Oosthyuzen W, Parys M, Gow A, Salavati Schmitz S J Vet Intern Med. 2024; 38(2):995-1004.

PMID: 38351718 PMC: 10937508. DOI: 10.1111/jvim.17009.


Primer Exchange Reaction Coupled with DNA-Templated Silver Nanoclusters for Label-Free and Sensitive Detection of MicroRNA.

Ning L, Li Y, Zhang Z, Zhou Y, Yang L, Yu Q Appl Biochem Biotechnol. 2023; 195(10):6334-6344.

PMID: 36862332 DOI: 10.1007/s12010-023-04420-1.


5-FU-miR-15a Inhibits Activation of Pancreatic Stellate Cells by Reducing YAP1 and BCL-2 Levels In Vitro.

Almanzar V, Shah K, LaComb J, Mojumdar A, Patel H, Cheung J Int J Mol Sci. 2023; 24(4).

PMID: 36835366 PMC: 9961454. DOI: 10.3390/ijms24043954.


The potential value of exosomes as adjuvants for novel biologic local anesthetics.

Zhang Y, Feng S, Cheng X, Lou K, Liu X, Zhuo M Front Pharmacol. 2023; 14:1112743.

PMID: 36778004 PMC: 9909291. DOI: 10.3389/fphar.2023.1112743.


References
1.
Barrow J, Balsa E, Verdeguer F, Tavares C, Soustek M, Hollingsworth 4th L . Bromodomain Inhibitors Correct Bioenergetic Deficiency Caused by Mitochondrial Disease Complex I Mutations. Mol Cell. 2016; 64(1):163-175. PMC: 5055448. DOI: 10.1016/j.molcel.2016.08.023. View

2.
Xin L, Gao J, Wang D, Lin J, Liao Z, Ji J . Novel blood-based microRNA biomarker panel for early diagnosis of chronic pancreatitis. Sci Rep. 2017; 7:40019. PMC: 5225423. DOI: 10.1038/srep40019. View

3.
Frampton A, Castellano L, Colombo T, Giovannetti E, Krell J, Jacob J . Integrated molecular analysis to investigate the role of microRNAs in pancreatic tumour growth and progression. Lancet. 2015; 385 Suppl 1:S37. DOI: 10.1016/S0140-6736(15)60352-X. View

4.
Aghdassi A, Weiss F, Mayerle J, Lerch M, Simon P . Genetic susceptibility factors for alcohol-induced chronic pancreatitis. Pancreatology. 2015; 15(4 Suppl):S23-31. DOI: 10.1016/j.pan.2015.05.476. View

5.
Conwell D, Lee L, Yadav D, Longnecker D, Miller F, Mortele K . American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines. Pancreas. 2014; 43(8):1143-62. PMC: 5434978. DOI: 10.1097/MPA.0000000000000237. View